260 related articles for article (PubMed ID: 16585872)
21. Prospective trial of voice outcomes after thyroidectomy: evaluation of patient-reported and clinician-determined voice assessments in identifying postthyroidectomy dysphonia.
Stojadinovic A; Henry LR; Howard RS; Gurevich-Uvena J; Makashay MJ; Coppit GL; Shriver CD; Solomon NP
Surgery; 2008 Jun; 143(6):732-42. PubMed ID: 18549889
[TBL] [Abstract][Full Text] [Related]
22. Treatment of adductor spasmodic dysphonia with selective laryngeal adductor denervation and reinnervation surgery.
Chhetri DK; Berke GS
Otolaryngol Clin North Am; 2006 Feb; 39(1):101-9. PubMed ID: 16469658
[No Abstract] [Full Text] [Related]
23. A comparison of the VHI, VHI-10, and V-RQOL for measuring the effect of botox therapy in adductor spasmodic dysphonia.
Morzaria S; Damrose EJ
J Voice; 2012 May; 26(3):378-80. PubMed ID: 20951552
[TBL] [Abstract][Full Text] [Related]
24. Clinical characteristics of essential voice tremor: a study of 34 cases.
Sulica L; Louis ED
Laryngoscope; 2010 Mar; 120(3):516-28. PubMed ID: 20066728
[TBL] [Abstract][Full Text] [Related]
25. Long-term results of type II thyroplasty for adductor spasmodic dysphonia.
Chan SW; Baxter M; Oates J; Yorston A
Laryngoscope; 2004 Sep; 114(9):1604-8. PubMed ID: 15475790
[TBL] [Abstract][Full Text] [Related]
26. Evaluating the outcome of phonosurgery: comparing the role of VHI and VoiSS questionnaires in the Greek language.
Kiagiadaki DE; Chimona TS; Chlouverakis GI; Stylianou Y; Proimos EK; Papadakis CE; Bizakis JG
J Voice; 2012 May; 26(3):372-7. PubMed ID: 21839613
[TBL] [Abstract][Full Text] [Related]
27. Surgery or botulinum toxin for adductor spasmodic dysphonia: a comparative study.
Mendelsohn AH; Berke GS
Ann Otol Rhinol Laryngol; 2012 Apr; 121(4):231-8. PubMed ID: 22606926
[TBL] [Abstract][Full Text] [Related]
28. Problems with surgical (RLN section) treatment of spastic dysphonia.
Dedo HH; Izdebski K
Laryngoscope; 1983 Mar; 93(3):268-71. PubMed ID: 6834947
[TBL] [Abstract][Full Text] [Related]
29. Thyroplasty for adductor spasmodic dysphonia: further experiences.
Isshiki N; Haji T; Yamamoto Y; Mahieu HF
Laryngoscope; 2001 Apr; 111(4 Pt 1):615-21. PubMed ID: 11359129
[TBL] [Abstract][Full Text] [Related]
30. Adductor spastic dysphonia: 1 1/2 years after recurrent laryngeal nerve resection.
Aronson AE; DeSanto LW
Ann Otol Rhinol Laryngol; 1981; 90(1 Pt 1):2-6. PubMed ID: 7469292
[TBL] [Abstract][Full Text] [Related]
31. Longitudinal effects of botulinum toxin injections on voice-related quality of life (V-RQOL) for patients with adductory spasmodic dysphonia.
Hogikyan ND; Wodchis WP; Spak C; Kileny PR
J Voice; 2001 Dec; 15(4):576-86. PubMed ID: 11792036
[TBL] [Abstract][Full Text] [Related]
32. Laser-assisted voice adjustment (LAVA) in transsexuals.
Orloff LA; Mann AP; Damrose JF; Goldman SN
Laryngoscope; 2006 Apr; 116(4):655-60. PubMed ID: 16585875
[TBL] [Abstract][Full Text] [Related]
33. The use of the pulse dye laser in the treatment of vocal fold scar: a preliminary study.
Mortensen MM; Woo P; Ivey C; Thompson C; Carroll L; Altman K
Laryngoscope; 2008 Oct; 118(10):1884-8. PubMed ID: 18641533
[TBL] [Abstract][Full Text] [Related]
34. The voice handicap index: correlation between subjective patient response and quantitative assessment of voice.
Woisard V; Bodin S; Yardeni E; Puech M
J Voice; 2007 Sep; 21(5):623-31. PubMed ID: 16887329
[TBL] [Abstract][Full Text] [Related]
35. Voice after supracricoid laryngectomy: subjective, objective and self-assessment data.
Schindler A; Favero E; Nudo S; Spadola-Bisetti M; Ottaviani F; Schindler O
Logoped Phoniatr Vocol; 2005; 30(3-4):114-9. PubMed ID: 16287650
[TBL] [Abstract][Full Text] [Related]
36. Treatment of adductor-type spasmodic dysphonia by surgical myectomy: a preliminary report.
Koufman JA; Rees CJ; Halum SL; Blalock D
Ann Otol Rhinol Laryngol; 2006 Feb; 115(2):97-102. PubMed ID: 16514790
[TBL] [Abstract][Full Text] [Related]
37. Results of ansa to recurrent laryngeal nerve reinnervation.
Lee WT; Milstein C; Hicks D; Akst LM; Esclamado RM
Otolaryngol Head Neck Surg; 2007 Mar; 136(3):450-4. PubMed ID: 17321876
[TBL] [Abstract][Full Text] [Related]
38. Voice outcomes of polyacrylamide hydrogel injection laryngoplasty.
Lee SW; Son YI; Kim CH; Lee JY; Kim SC; Koh YW
Laryngoscope; 2007 Oct; 117(10):1871-5. PubMed ID: 17690620
[TBL] [Abstract][Full Text] [Related]
39. Selective denervation: reinnervation for the control of adductor spasmodic dysphonia.
Allegretto M; Morrison M; Rammage L; Lau DP
J Otolaryngol; 2003 Jun; 32(3):185-9. PubMed ID: 12921138
[TBL] [Abstract][Full Text] [Related]
40. [The smokers voice self assessment based on Voice Handicap Index (VHI)].
Wiskirska-Woźnica B; Wojnowski W
Przegl Lek; 2009; 66(10):565-6. PubMed ID: 20301881
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
